Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase

• Martina Ott,

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Helmholtz Group Experimental Neuroimmunology and Clinical Cooperation Unit, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Ulrike M. Litzenburger,

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Helmholtz Group Experimental Neuroimmunology and Clinical Cooperation Unit, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Felix Sahm,

  Affiliations Institute for Neuropathology, University Hospital Heidelberg, Heidelberg, Germany, Department of Neuropathology, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Katharina J. Rauschenbach,

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Helmholtz Group Experimental Neuroimmunology and Clinical Cooperation Unit, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Ruxandra Tudoran,

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Helmholtz Group Experimental Neuroimmunology and Clinical Cooperation Unit, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Christian Hartmann,

  Affiliations Institute for Neuropathology, University Hospital Heidelberg, Heidelberg, Germany, Department of Neuropathology, German Cancer Research Center, Heidelberg, Germany, Department of Neuropathology, Institute for Pathology, Hannover Medical School, Hannover, Germany

  ⨯
• Victor E. Marquez,

  Affiliation Chemical Biology Laboratory, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Andreas von Deimling,

  Affiliations Institute for Neuropathology, University Hospital Heidelberg, Heidelberg, Germany, Department of Neuropathology, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Wolfgang Wick,

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Department of Neurooncology, German Cancer Research Center, Heidelberg, Germany

  ⨯
• Michael Platten

  * E-mail: michael.platten@med.uni-heidelberg.de

  Affiliations Department of Neurooncology, University Hospital Heidelberg, Heidelberg, Germany, Helmholtz Group Experimental Neuroimmunology and Clinical Cooperation Unit, German Cancer Research Center, Heidelberg, Germany

  ⨯